Mei T Liu
Mei T Liu
Stimulant use disorder (SUD) is a public health problem in the United States that is associated with increased morbidity and mortality. Psychosocial interventions, such as cognitive behavioral therapy and contingency management, are the mai...
Jennifer Miller
Jennifer Miller
Acute agitation and aggression create safety risks for both patients and staff, often leading to psychiatric emergencies. Quick and appropriate treatment is necessary to achieve safe and effective outcomes. Unfortunately, there are several ...
Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing [0.03%]
儿童患者长期使用抗抑郁药、情绪稳定剂和抗精神病药物，重点是合理减少用药
Danielle L Stutzman
Danielle L Stutzman
It is estimated that 8% to 12% of youth are prescribed psychotropic medications. Those in foster care, juvenile justice systems, residential treatment facilities, and with developmental or intellectual disabilities are more likely to be pre...
Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome [0.03%]
抗精神病药物引起代谢综合征的监测和治疗的经验之谈
Beth M DeJongh
Beth M DeJongh
Antipsychotic medications increase the risk of metabolic syndrome, which then increases the risk of atherosclerotic cardiovascular disease and premature death. Routinely monitoring for signs of metabolic syndrome in patients taking antipsyc...
The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia [0.03%]
帕利哌酮棕榈酸酯与阿立哌唑单水合治疗精神分裂症患者的长期注射抗精神病药物疗法的联合应用研究
Christopher Evernden,Irene Giang,Mariah Anderson
Christopher Evernden
International schizophrenia guidelines endorse seeking the patient's preference for guiding antipsychotic therapy. There exists a small niche of patients who prefer, or are required to use, long-acting injectable antipsychotic medications d...
Probable haloperidol decanoate-induced fever in an African American with benign ethnic neutropenia: A case report [0.03%]
一例良性族系性中性粒细胞减少的非裔美国人出现可能由氟丙醇酰胺引起的发热：病例报告
Lara Youniss,Michele Thomas,Erica A K Davis
Lara Youniss
We present a case in which a patient developed fever and leukocytosis subsequent to each monthly haloperidol decanoate injection, an adverse reaction that does not meet the diagnostic criteria of neuroleptic malignant syndrome (NMS) or any ...
Possible inhibitory effects of terbinafine on aripiprazole metabolism: Two case reports [0.03%]
特比萘芬对阿立哌唑代谢的潜在抑制作用：两例病例报告
Ian R McGrane,Tori J Lindbloom,Robert C Munjal
Ian R McGrane
Aripiprazole, an atypical antipsychotic, is a metabolic substrate for cytochrome P450 (CYP)3A4 and 2D6. Terbinafine, an antifungal agent used for onychomycosis, is a CYP2D6 inhibitor and could theoretically reduce the metabolism of aripipra...
COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital [0.03%]
长期住院精神病患者中患有严重精神疾病且再次感染COVID-19的病人
Brianna Englett,Amy Magdalany,Tiffany L Gordon et al.
Brianna Englett et al.
There is an increasing number of case reports of COVID-19 reinfection. The mechanism of reinfection is poorly understood and evolving. Prevention of the transmission of severe acute respiratory syndrome coronavirus 2 for those with a seriou...
Carbamazepine drug reaction involving high fevers during the COVID-19 era [0.03%]
在COVID-19期间一种引起高热的卡马西平药物反应
Reuben Heyman-Kantor,Matthew Perez,Arti Phatak et al.
Reuben Heyman-Kantor et al.
Carbamazepine has demonstrated anticonvulsant properties and is used for a variety of indications in psychiatry and neurology. Total daily doses typically range from 200 to 1200 mg/d, generally divided into 2 doses. Carbamazepine has a broa...
Disability and workers' compensation trends for employees with mental disorders and SUDs in the United States [0.03%]
美国患有精神疾病和SUDs的员工伤残和工人赔偿趋势
Richard A Brook,Nathan L Kleinman,Ian A Beren
Richard A Brook
Introduction: US employee absence benefits may include workers' compensation (WC) for work-related injuries/illnesses, short- and long-term disability (STD and LTD, respectively) for non-work-related injuries/illnesses, a...